Covered recipient · General Payments record
STEPHEN T OH
Allopathic & Osteopathic Physicians Internal Medicine Hematology
General Payments · PY2018–2024
$112,369.45
- Reported across 111 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $17,577.50 | 7 |
| Honoraria | $2,156.00 | 1 |
| Food and Beverage | $241.44 | 4 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Incyte Corporation | $8,562.50 | 2 |
| GlaxoSmithKline, LLC. | $4,892.77 | 3 |
| E.R. Squibb & Sons, L.L.C. | $2,943.67 | 2 |
| Blueprint Medicines Corporation | $2,156.00 | 1 |
| ABBVIE INC. | $1,350.00 | 2 |
| Celgene Corporation | $70.00 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (12)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $337.50 | 01/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105148326 | CMS |
| ABBVIE INC. | $1,012.50 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1105148328 | CMS |
| Blueprint Medicines Corporation | $2,156.00 | 01/15/2024 | Honoraria | Undisputed | 01/23/2026 | 1147439616 | CMS |
| Celgene Corporation | $25.00 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101084675 | CMS |
| Celgene Corporation | $45.00 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101084677 | CMS |
| E.R. Squibb & Sons, L.L.C. | $2,865.00 | 09/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1101228891 | CMS |
| E.R. Squibb & Sons, L.L.C. | $78.67 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101228895 | CMS |
| GlaxoSmithKline, LLC. | $3,200.00 | 01/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116352868 | CMS |
| GlaxoSmithKline, LLC. | $92.77 | 04/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116506065 | CMS |
| GlaxoSmithKline, LLC. | $1,600.00 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116397762 | CMS |
| Incyte Corporation | $1,370.00 | 05/13/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141217690 | CMS |
| Incyte Corporation | $7,192.50 | 09/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1141183982 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.